September 29, 2016 12:50 AM ET

Capital Markets

Company Overview of Novartis Venture Funds

Company Overview

Novartis Venture Funds is a private equity and venture capital arm of Novartis AG specializing in investments in early startup companies, seed, growth capital, Series A, and later stage investment. The firm is stage agnostic and makes early, mid and late venture investments. It seeks to invest in biotech/biopharma, medical devices and diagnostics, and life sciences companies with a focus on new novel therapeutics and platforms; medical devices and implants; diagnostics and biomarkers; and drug delivery and biopolymers. The firm primarily invests globally focusing on private and public companies based in North America with a focus on the United States, Canada, Europe, Switzerland, Israel, and...

Postfach

Basel,  4002

Switzerland

Founded in 1996

Phone:

41 61 324 32 67

Fax:

41 61 324 86 79

Key Executives for Novartis Venture Funds

President
Age: 60
Managing Director
Age: 39
Managing Director
Managing Director
Age: 48
Compensation as of Fiscal Year 2016.

Novartis Venture Funds Key Developments

Novartis Venture Funds Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 09:15 AM

Novartis Venture Funds Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 09:15 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Speakers: Markus Goebel, Managing Director.

Novartis Venture Funds Presents at Go4Israel Conference, Oct-27-2014 02:00 PM

Novartis Venture Funds Presents at Go4Israel Conference, Oct-27-2014 02:00 PM. Venue: Hilton Hotel, Tel Aviv, Israel. Speakers: Florent Gros, Managing Director.

Similar Private Companies By Industry

Company Name Region
“The Lantern” Research Sagl Europe
2thePoint AG Europe
A&a Bull And Bear Europe
AAA Corporate Finance Advisers AG Europe
Abrir Capital Advisors AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 11, 2016
Inflazome Ltd.
Private Placement
September 6, 2016
ROX Medical, Inc.
Private Placement
June 23, 2016
Annexon Biosciences, Inc.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novartis Venture Funds, please visit www.nvfund.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.